What is the usual dose of naltrexone for treating opioid dependence or alcohol use disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Usual Dose of Naltrexone

For alcohol use disorder, the standard dose is 50 mg once daily by mouth, or 380 mg intramuscularly once monthly. 1

Oral Naltrexone Dosing

For Alcohol Use Disorder

  • Standard dose: 50 mg once daily 1
  • This dosing regimen was validated in placebo-controlled trials demonstrating efficacy for up to 12 weeks 1
  • The 50 mg daily dose has a number needed to treat of 18 to prevent one person from returning to any drinking, and 11 to prevent return to heavy drinking 2

For Opioid Dependence

  • Initial dose: 25 mg on day 1 to assess for precipitated withdrawal 1
  • Maintenance dose: 50 mg once daily if no withdrawal signs occur 1
  • This dose provides adequate clinical blockade of parenterally administered opioids 1

Alternative Dosing Schedules

For supervised administration settings, flexible regimens may be used 1:

  • 50 mg every weekday with 100 mg on Saturday
  • 100 mg every other day
  • 150 mg every third day

Important caveat: Single doses above 50 mg carry higher risk of hepatocellular injury, so extended dosing intervals should balance risks against benefits 1

Injectable Naltrexone Dosing

For Alcohol Use Disorder

  • 380 mg intramuscularly once monthly (Vivitrol) 3
  • This formulation resulted in a 25% decrease in heavy drinking days compared to placebo 4
  • Injectable naltrexone reduced drinking days by approximately 5 days over a 30-day period 5
  • The monthly injection addresses adherence challenges inherent to daily oral therapy 4

For Opioid Dependence

  • 380 mg intramuscularly once monthly 3
  • FDA-approved for this indication following approval for alcohol dependence 3

Critical Pre-Treatment Requirements

Patients must be opioid-free before starting naltrexone to avoid precipitated withdrawal 1:

  • Minimum 7-10 days opioid-free for short-acting opioids 1
  • Patients transitioning from buprenorphine or methadone may be vulnerable to precipitated withdrawal for up to 2 weeks 1
  • Consider naloxone challenge test if occult opioid dependence is suspected 1

Monitoring Requirements

  • Baseline liver function tests and repeat every 3-6 months 3
  • Naltrexone has been associated with hepatic injury at supratherapeutic doses 3
  • Recent evidence suggests naltrexone is safe even in patients with severe alcohol-associated cirrhosis 6

Clinical Context

Naltrexone should be part of a comprehensive treatment plan including psychosocial interventions 1. The medication works by blocking mu-opioid receptors, preventing the euphoric effects of alcohol and opioids and reducing craving 3. Evidence supports both oral naltrexone at 50 mg daily and acamprosate as first-line pharmacotherapies for alcohol use disorder when combined with psychosocial support 2.

For perioperative management, oral naltrexone should be held 2-3 days before elective surgery if opioids will be needed, while injectable naltrexone requires 24-30 days after the last injection 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.